| Product Code: ETC9519189 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Suriname Pharmacogenetic Testing Market Overview |
3.1 Suriname Country Macro Economic Indicators |
3.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Suriname Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Suriname Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Suriname Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Suriname Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and adoption of personalized medicine in Suriname |
4.2.2 Rising prevalence of chronic diseases requiring personalized treatment |
4.2.3 Government initiatives promoting precision medicine in healthcare |
4.3 Market Restraints |
4.3.1 Limited availability of skilled healthcare professionals for interpreting pharmacogenetic test results |
4.3.2 High costs associated with pharmacogenetic testing and related treatments in Suriname |
5 Suriname Pharmacogenetic Testing Market Trends |
6 Suriname Pharmacogenetic Testing Market, By Types |
6.1 Suriname Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Suriname Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Suriname Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Suriname Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Suriname Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Suriname Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Suriname Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Suriname Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Suriname Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Suriname Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Suriname Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Suriname Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Suriname Pharmacogenetic Testing Market Export to Major Countries |
7.2 Suriname Pharmacogenetic Testing Market Imports from Major Countries |
8 Suriname Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services |
8.2 Percentage of healthcare professionals trained in pharmacogenetics |
8.3 Patient satisfaction rate with pharmacogenetic testing services |
8.4 Number of research studies or publications on pharmacogenetic testing in Suriname |
8.5 Adoption rate of pharmacogenetic testing in clinical practice |
9 Suriname Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Suriname Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Suriname Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Suriname Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Suriname Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here